EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pre-diabetes and Diabetes in Heart Transplant Recipients: Epidemiological Insights from a Decade-Long Study

Sanaz Soleimani iD, Fatemeh Kazemi Hasnijeh iD, Maryam Vasheghani iD, Farah Naghashzadeh iD, Zargham Hossein Ahmadi iD, Babak Sharif Kashani iD, Fatemeh Nouri iD, Niloufar Alizadeh Kolahdozi iD, Shadi Shafaghi iD

International Journal of Endocrinology and Metabolism · 22.06.2026 · 24 (4)

DOI: 10.5812/ijem-168325 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Endocrinology and Metabolism, online erschienen am 22.06.2026. Verfasst von Sanaz Soleimani und 8 weiteren Autor:innen. Beteiligte Einrichtung: Lung Transplantation Research Center (LTRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Me…. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Post-transplant diabetes mellitus (PTDM) is a serious complication after heart transplantation, with reported incidence rates ranging from 2% to 53% among solid organ transplant recipients. Comprehensive epidemiological data on prediabetes (Pre-DM) and diabetes mellitus (DM) in heart transplant populations remain limited, particularly in Middle Eastern populations.

Objectives

This decade-long study investigated the prevalence of DM and Pre-DM among heart transplant recipients and evaluated selected intraoperative risk factors.

Methods

This retrospective cohort study included 250 heart transplant recipients who received post-transplant care at Dr. Masih Daneshvari Hospital, Tehran, Iran, between 2010 and 2020. Overall, 244 patients were included in the final analysis. Data included anthropometric measurements, cardiovascular parameters, and metabolic profiles. Pre-DM and DM were diagnosed according to the American Diabetes Association criteria. Statistical analyses were performed using SPSS version 26.

Results

The study population comprised 192 males (78.7%) and 52 females (21.3%), with a mean age of 38.46 ± 12.69 years. At transplantation, 36.5% of recipients had established DM, 29.1% had Pre-DM, and 34.4% had normal glucose metabolism. Among patients with DM, 58.4% (52 of 89) were unaware of their diagnosis before transplantation. New-onset PTDM occurred in 6.8% of previously normoglycemic patients by 6 months. The prevalence of hypertension differed markedly by glucose status (P < 0.001): 100% of the normal group had normal blood pressure, 97.2% of patients with Pre-DM had stage 1 hypertension, and 87.6% of patients with DM had stage 2 hypertension. Dyslipidemia, particularly low high-density lipoprotein (HDL), was present in all groups. Pre-transplant hyperglycemia was associated with a numerically higher, but nonsignificant, mortality risk (hazard ratio [HR] = 1.371; 95% CI, 0.891 - 2.132; P = 0.162), which reversed after age adjustment (HR = 0.676; P = 0.083), consistent with negative confounding.

Conclusions

Pre-transplant metabolic dysfunction was highly prevalent, and 58.4% of diabetic recipients were unaware of their diagnosis. Although the association with mortality was nonsignificant and reversed after adjustment for age, these findings underscore the need for systematic pre-transplant metabolic screening, post-transplant glucose monitoring, and multidisciplinary care in heart transplant recipients.

Schlagwörter

Stichwörter der Autor:innen

DiabetesEpidemiologyHeart TransplantPrediabetesTreatment Outcome

Autor:innen und Institutionen

  • Lung Transplantation Research Center (LTRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Chronic Respiratory Diseases Research Center (CRDRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Tobacco Prevention and Control Research Center, National Research Institute of Tuberculosis and Lun Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of Biostatistics, National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Sanaz Soleimani, Fatemeh Kazemi Hasnijeh, Maryam Vasheghani, Farah Naghashzadeh, Zargham Hossein Ahmadi, Babak Sharif Kashani, Fatemeh Nouri, Niloufar Alizadeh Kolahdozi, Shadi Shafaghi

Zitieren

APA

Soleimani, S., Kazemi Hasnijeh, F., Vasheghani, M., Naghashzadeh, F., Ahmadi, Z. H., Sharif Kashani, B., Nouri, F., Alizadeh Kolahdozi, N., & Shafaghi, S. (2026). Pre-diabetes and Diabetes in Heart Transplant Recipients: Epidemiological Insights from a Decade-Long Study. International Journal of Endocrinology and Metabolism, 24(4). https://doi.org/10.5812/ijem-168325

Vancouver

Soleimani S, Kazemi Hasnijeh F, Vasheghani M, Naghashzadeh F, Ahmadi ZH, Sharif Kashani B, et al. Pre-diabetes and Diabetes in Heart Transplant Recipients: Epidemiological Insights from a Decade-Long Study. International Journal of Endocrinology and Metabolism. 2026;24(4). doi:10.5812/ijem-168325

BibTeX
@article{Soleimani2026,
  author = {Soleimani, Sanaz and Kazemi Hasnijeh, Fatemeh and Vasheghani, Maryam and Naghashzadeh, Farah and Ahmadi, Zargham Hossein and Sharif Kashani, Babak and Nouri, Fatemeh and Alizadeh Kolahdozi, Niloufar and Shafaghi, Shadi},
  title = {Pre-diabetes and Diabetes in Heart Transplant Recipients: Epidemiological Insights from a Decade-Long Study},
  journal = {International Journal of Endocrinology and Metabolism},
  year = {2026},
  volume = {24},
  number = {4},
  doi = {10.5812/ijem-168325}
}
Kostenlos starten →